Evolution of Technologies for Therapeutic Antibodies - From mAbs to Biosimilars, New Report Launched
The scope of the report is to highlight and gauge existing technologies in the production of therapeutic mAbs. The report also discusses key insights on interchangeability and substitution of therapeutic antibodies and biosimilars.
View full press release